Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: May 12, 2023
Open Peer Review Period: Mar 17, 2023 - May 12, 2023
Date Accepted: Sep 8, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study

Gandelin M, Tran P, Chirpaz E, Jaffar-Bandjee MC, Traversier N, Machalek D, Bertolotti A

Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study

JMIR Res Protoc 2023;12:e47379

DOI: 10.2196/47379

PMID: 37906221

PMCID: 10646676

Human Papillomavirus (HPV) Infections among Participants in the Chlamydia Trachomatis Testing in Reunion Island (RUN-SurV-HPV): a Protocol for a Prevalence Study

  • Maxence Gandelin; 
  • Phuong Tran; 
  • Emmanuel Chirpaz; 
  • Marie-Christine Jaffar-Bandjee; 
  • Nicolas Traversier; 
  • Dorothy Machalek; 
  • Antoine Bertolotti

ABSTRACT

Background:

Infection by human papillomavirus (HPV) induces various cancers, mainly cervical cancer, but also anal and pharyngeal cancer. Regarding cervical cancer, its frequency and mortality are clearly higher in Reunion Island than in mainland France. However, vaccination coverage in France and especially in Reunion Island has remained very low so far.

Objective:

To describe the prevalence of infections by different HPV genotypes in a population at risk of sexually transmitted infections. To describe the prevalence of different genotypes of HPV infection by gender, by sexuality and by swab site. To describe the correlates and risk factors for HPV infection. To compare the distribution of different HPV types by swab site in the same patient.

Methods:

Single-centre cross-sectional descriptive study on data collected from October 2020 to December 2022 from vaginal, anal, pharyngeal and/or urinary regions swab samples collected during screening for Chlamydia trachomatis in patients attending a sexually transmitted infection screening centre. HPV detection and genotyping will be performed by Anyplex II HPV28 Detection (Seegene Inc) PCR.

Results:

This study will analyse 1200 samples collected from women and men. These results will be correlated with socio-demographic and clinical data collected via a self-administered questionnaire during the consultation.

Conclusions:

This study will make it possible to obtain an estimate of HPV prevalence of in a population at risk of sexually transmitted infections according to, among other things, age, gender, sexuality, HIV status and location prior to a large-scale vaccination campaign against HPV. Collecting data from young patients who are not routinely screened will help evaluate effectiveness of future vaccination campaigns on HPV infection.


 Citation

Please cite as:

Gandelin M, Tran P, Chirpaz E, Jaffar-Bandjee MC, Traversier N, Machalek D, Bertolotti A

Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study

JMIR Res Protoc 2023;12:e47379

DOI: 10.2196/47379

PMID: 37906221

PMCID: 10646676

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.